Trials / Recruiting
RecruitingNCT07052604
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Centre Hospitalier de Saint-Denis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.
Conditions
- Pneumonia, Ventilator-Associated
- Stenotrophomonas Maltophilia
- Intensive Care Units
- Anti-Bacterial Agents
- Drug Resistance, Bacterial
Timeline
- Start date
- 2023-12-15
- Primary completion
- 2025-09-15
- Completion
- 2025-09-15
- First posted
- 2025-07-04
- Last updated
- 2025-07-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07052604. Inclusion in this directory is not an endorsement.